The first drug that has been approved in the United States to lower proprotein convertase subtilisin Kexin 9 (PCSK-9) is:

Question

Quizplus · Accepted Answer

D) The first drug approved in the United States to lower proprotein convertase subtilisin Kexin 9 (PCSK-9) is alirocumab (Praluent ). The gene, PCSK-9, is important for plasma cholesterol metabolism. Alirocumab is administered by injection, and is indicated for familial hypercholesterolemia, or for patients with a history of heart disease in whom statins are not sufficiently effective.

The First Drug That Has Been Approved in the United